fbpx
QQQ
+ 2.19
278.28
+ 0.78%
DIA
-2.30
279.39
-0.83%
SPY
-1.15
340.63
-0.34%
TLT
+ 1.07
158.41
+ 0.67%
GLD
+ 0.53
178.00
+ 0.3%

Vitality Biopharma Hires Investment Bank To Explore M&A, Asset Sale Opportunities

September 25, 2020 12:35 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Drug development company Vitality Biopharma Inc. (OTCQB:VBIOhas tapped financial adviser DelMorgan & Co. to manage a potential sale process.

Neil Morganbesser, DelMorgan's President and CEO, said “the right partner — either through M&A or a capital infusion — could be the key to unlocking Vitality’s explosive growth potential."

Vitality’s portfolio consists of cannabinoid drugs and new treatments for Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).

Vitality CEO Michael Cavanaugh said he was “thrilled” that Santa Monica, California-based DelMorgan opted to help the company “evaluate strategic alternatives," including asset divestitures, potential financing deals and strategic partnerships.

DelMorgan has a “deep capital markets expertise and well-earned trust within the investment community,” which is essential in guiding the Los Angeles-headquartered company “through the process of evaluating strategic alternatives to maximize value for all of our shareholders,” added Cavanaugh.

4Front, Auxly Resort to Asset Sale To Provide Funding

Several other companies within the cannabis industry have recently opted to sell assets or seek additional funding. 

On Thursday, 4Front Ventures Corp. (OTCQX:FFNTFconfirmed a $5.5 million sale of three Maryland-based dispensaries to Ethos Cannabis.

The Phoenix-based company intends to utilize the funds to pay down debts to the New York-based private equity firm Gotham Green Partners. 

Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) recently decreased its stake in Inner Spirit Holdings Ltd. from 12.9% to 9.8%, which brought it $850,000 in gross proceeds.

Besides some 6 million common shares of Inner Spirit, the Toronto-based company also disposed of $400,000 worth of its convertible debentures.

Courtesy image


Related Articles

Cannabis Movers & Shakers: Blueberries, Harborside, HEXO, Christina Lake, RespireRx

Here is a summary of the latest leadership changes within the cannabis industry. Blueberries Parts Ways With CEO Camilo Villalba  read more

Real Brands Closes Merger With Canadian American Standard Hemp

Real Brands Inc. (OTCPK: RLBD) confirmed Tuesday, it has finalized the acquisition of Canadian American Standard Hemp Inc. read more

Turning Point Brands Backs Cannabinoid Company Dosist With $15M

Turning Point Brands Inc. (NYSE: TPB) agreed to invest $15 million in Dosist, a cannabinoid company. The two companies opted to co-create a new CBD brand featuring thc-free products.  read more

Neptune Partners With Ontario Cannabis Store, Brings Products To 515 Canada Stores

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) partnered with Ontario Cannabis Store to sell and distribute Mood Ring, a new proprietary recreational product line. Under the supply deal, the Mood Ring product line would be commercialized in 211 Ontario-based private retailers. read more

Flow Cannabis CEO On Post-Election Policy Hopes, Strategy On Heels Of Caldera Launch

Flow Cannabis Co. recently launched Caldera, a line of premium extracts, vape cartridges, oils, and concentrates defined by their purity, potency and flavor. read more